236 related articles for article (PubMed ID: 26184912)
1. BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma.
Carter MJ; Cox KL; Blakemore SJ; Bogdanov YD; Happo L; Scott CL; Strasser A; Packham GK; Cragg MS
Cell Death Differ; 2016 Feb; 23(2):303-12. PubMed ID: 26184912
[TBL] [Abstract][Full Text] [Related]
2. Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis.
Coultas L; Bouillet P; Loveland KL; Meachem S; Perlman H; Adams JM; Strasser A
EMBO J; 2005 Nov; 24(22):3963-73. PubMed ID: 16270031
[TBL] [Abstract][Full Text] [Related]
3. Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.
Happo L; Phipson B; Smyth GK; Strasser A; Scott CL
Cell Death Dis; 2012 May; 3(5):e306. PubMed ID: 22573037
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal Domains of Apoptotic BH3-only Proteins Mediate Their Insertion into Distinct Biological Membranes.
Andreu-Fernández V; García-Murria MJ; Bañó-Polo M; Martin J; Monticelli L; Orzáez M; Mingarro I
J Biol Chem; 2016 Nov; 291(48):25207-25216. PubMed ID: 27758854
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.
Inoue S; Riley J; Gant TW; Dyer MJ; Cohen GM
Leukemia; 2007 Aug; 21(8):1773-82. PubMed ID: 17525724
[TBL] [Abstract][Full Text] [Related]
6. Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression.
Mérino D; Strasser A; Bouillet P
Oncogene; 2012 Jul; 31(28):3392-6. PubMed ID: 22081075
[TBL] [Abstract][Full Text] [Related]
7. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts.
González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J
Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481
[TBL] [Abstract][Full Text] [Related]
8. Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.
Kuroda J; Puthalakath H; Cragg MS; Kelly PN; Bouillet P; Huang DC; Kimura S; Ottmann OG; Druker BJ; Villunger A; Roberts AW; Strasser A
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14907-12. PubMed ID: 16997913
[TBL] [Abstract][Full Text] [Related]
9. A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity.
Ponassi R; Biasotti B; Tomati V; Bruno S; Poggi A; Malacarne D; Cimoli G; Salis A; Pozzi S; Miglino M; Damonte G; Cozzini P; Spyrakis F; Campanini B; Bagnasco L; Castagnino N; Tortolina L; Mumot A; Frassoni F; Daga A; Cilli M; Piccardi F; Monfardini I; Perugini M; Zoppoli G; D'Arrigo C; Pesenti R; Parodi S
Cell Cycle; 2008 Oct; 7(20):3211-24. PubMed ID: 18843207
[TBL] [Abstract][Full Text] [Related]
10. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo.
Erlacher M; Michalak EM; Kelly PN; Labi V; Niederegger H; Coultas L; Adams JM; Strasser A; Villunger A
Blood; 2005 Dec; 106(13):4131-8. PubMed ID: 16118324
[TBL] [Abstract][Full Text] [Related]
11. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells.
Obexer P; Geiger K; Ambros PF; Meister B; Ausserlechner MJ
Cell Death Differ; 2007 Mar; 14(3):534-47. PubMed ID: 16888645
[TBL] [Abstract][Full Text] [Related]
12. 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines.
Zagorodna O; Martin SM; Rutkowski DT; Kuwana T; Spitz DR; Knudson CM
Oncogene; 2012 May; 31(22):2738-49. PubMed ID: 21986940
[TBL] [Abstract][Full Text] [Related]
13. Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells.
Kutuk O; Letai A
Cell Death Differ; 2010 Oct; 17(10):1624-35. PubMed ID: 20431602
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
[TBL] [Abstract][Full Text] [Related]
15. The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist.
Rautureau GJ; Yabal M; Yang H; Huang DC; Kvansakul M; Hinds MG
Cell Death Dis; 2012 Dec; 3(12):e443. PubMed ID: 23235460
[TBL] [Abstract][Full Text] [Related]
16. BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma.
Shao Y; Aplin AE
Cell Death Differ; 2012 Dec; 19(12):2029-39. PubMed ID: 22858545
[TBL] [Abstract][Full Text] [Related]
17. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31.
Takada E; Hata K; Mizuguchi J
Exp Cell Res; 2006 Nov; 312(19):3728-38. PubMed ID: 17007835
[TBL] [Abstract][Full Text] [Related]
18. Bim regulates BCR-induced entry of B cells into the cell cycle.
Craxton A; Draves KE; Clark EA
Eur J Immunol; 2007 Oct; 37(10):2715-22. PubMed ID: 17705137
[TBL] [Abstract][Full Text] [Related]
19. FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.
Kiyota M; Kuroda J; Yamamoto-Sugitani M; Shimura Y; Nakayama R; Nagoshi H; Mizutani S; Chinen Y; Sasaki N; Sakamoto N; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
Apoptosis; 2013 Nov; 18(11):1437-1446. PubMed ID: 23851982
[TBL] [Abstract][Full Text] [Related]
20. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins.
Tabrizi SJ; Niiro H; Masui M; Yoshimoto G; Iino T; Kikushige Y; Wakasaki T; Baba E; Shimoda S; Miyamoto T; Hara T; Akashi K
J Immunol; 2009 Feb; 182(3):1490-9. PubMed ID: 19155496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
